EdwardVincentLoftusJr.MDFACP, FACG, AGAF

PubMed

• Differentiating clinical characteristics of perianal inflammatory bowel disease from perianal hidradenitis suppurativa.
  Mika Yamanaka-Takaichi, Soheila Nadalian, Edward V Loftus, Eric C Ehman Jr, Austin Todd
  International Journal of Dermatology. 2024-09-22
• Home-based Biologic Infusions for Inflammatory Bowel Disease: Are We Ready for Prime Time?
  Raseen Tariq, Edward V Loftus Jr
  Inflammatory Bowel Diseases. 2024-09-03
• Characteristics, Clinical Outcomes, and Prognosis of Anal and Pouch-related Carcinoma in Patients With Crohn's Disease.
  Tanita Suttichaimongkol, Edward V Loftus Jr
  Inflammatory Bowel Diseases. 2024-04-03

Journal Articles

• Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium  
  Leah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
• Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto Consensus  
  Edward V Loftus, Edward V Loftus, David Schwartz, David Schwartz, Inflammatory Bowel Diseases
• Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium  
  Gursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
• Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients with Crohn’s Disease with up to 6 Years of Follow-up in the Pyramid Registry  
  Edward V Loftus, Roopal Thakkar, Nature
• Outcomes of Endoscopic Therapy for Luminal Strictures in Crohn’s Disease  
  John Kisiel, Edward V Loftus, David H Bruining, Raina Shivashankar, Inflammatory Bowel Diseases
• Co-existent pulmonary granulomatosis with polyangiitis (Wegener's) and Crohn's disease  
  Vaszar LT, Orzechowski NM, Specks U, Ytterberg SR, Loftus EV Jr, Mark EJ, Tazelaar HD, Am J Surg Pathol, 3/1/2014
• Designing a national inflammatory bowel disease surveillance program  
  Long MD, Hutfless S, Kappelman MD, Khalili H, Kaplan G, Bernstein C, Colombel JF, Walker A, Herrinton L, Velayos F, Loftus EV Jr et al, Inflamm Bowel Dis, 2/1/2014
• A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease  
  Bernstein CN, Ng SC, Lakatos PL, Moum B, Loftus EV Jr, Epidemiology and Natural History Task Force of the International Organization of the Study of Inflammatory Bowel..., Inflamm Bowel Dis, 8/1/2013
• Incidence of Spondyloarthropathy in patients with ulcerative colitis: a population-based study  
  Shivashankar R, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Matteson EL, J Rheumatol, 7/1/2013
• Direct costs of diverticulitis in a US managed care population  
  Yen L, Davis KL, Hodgkins P, Loftus EV Jr, Haim Erder M, American Journal of Pharmacy Benefits, 1/1/2012
• Inflammatory bowel disease: diagnosis and therapeutics Cohen RD (Book Review)  
  Loftus EV, Gastroenterology, 1/1/2012
• Development of the Crohn's disease digestive damage score, the Lemann score  
  Pariente B, Cosnes J, Danese S, Sandborn WJ, Lewin M, Fletcher JG, Chowers Y, D'Haens G, Feagan BG, Hibi T, Hommes DW, Irvine EJ, Kamm MA, Loftus EV et al, Inflamm Bowel Dis, 6/1/2011
• Commentary  
  Loftus EV Jr, Gastroenterol Hepatol, 1/1/2011
• Perioperative anti-tumornecrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease  
  Nasir BS, Dozois EJ, Cima RP, Pemberton JH, Wolff BG, Sandborn WJ, Loftus EV, Larson DW, J Gastrointest Surg, 1/1/2010
• Overview: Commentary  
  Loftus EV Jr, Gastroenterol Hepatol, 1/1/2010
• Clinical updates on the use of biologic agents in patients with Crohn's disease  
  Loftus EV, Gastroenterol Hepatol, 1/1/2010
• Ultrasound-enteroclysis for Crohn's disease: The best of both worlds?  
  Bruining DH, Loftus EV, Inflamm Bowel Dis, 2/1/2008
• Optimizing biologic therapies in the treatment of Crohn's disease: Commentary  
  Loftus EV, Gastroenterol Hepatol, 1/1/2008
• Certolizumab pegol reduces symptoms in patients with moderately to severely active Crohn's disease - Commentary  
  Loftus EV Jr, Evidence-Based Gastroenterol, 1/1/2008
• Examining patient populations across clinical trials of biologics  
  Loftus EV, Gastroenterol Hepatol, 1/1/2008
• Clinical trials in biologic therapy for Crohn's disease: Comparing designs and data  
  Lichtenstein GR, Hanauer SB, Loftus EV Jr, Gastroenterol Hepatol, 1/1/2008
• Epidemiology of microscopic colitis - Authors' response  
  Pardi DS, Loftus EV, Melton LJ, Zinsmeister AR, Gut, 7/1/2007
• Maximizing compliance and efficacy in the use of 5-ASA formulations for ulcerative colitis: Commentary  
  Loftus EV, Gastroenterol Hepatol, 1/1/2007
• The risk of colorectal cancer in ulcerative colitis in a population-based setting - Reply  
  Jess T, Loftus EV, Gastroenterology, 8/1/2006
• Contemporary management of ulcerative colitis: the patient's perspective  
  Loftus EV, Kane SV, Lichtensetein GR, Sandborn WJ, Gastroenterology & Hepatology, 1/1/2006
• Join now to see all

Books/Book Chapters

• GI Epidemiology: Diseases and Clinical Methodology. 
  Chapter: Epidemiology of Inflammatory Bowel Disease. 
  Page 273 - 284Talley NJ, Locke GR III, Moayyedi P, West J, Ford AC, Saito YAWiley, West Sussex, UKEdition 2nd,2014
• Clinical challenges and complications of IBD. 
  Chapter: Hepatobiliary Disease. 
  Page 175 - 194Regueiro MD, Swoger JMSLACK, Thorofare, NJ2013
• Curbside Consultation in IBD: 49 Clinical Questions. 
  Chapter: What is the best medical therapy for IBD in the elderly? Are anti-TNFs safe in the patient population? 
  Friedman RD, Farraye FSLACK, Inc.Edition 2nd,2013
• Crohn's disease and ulcerative colitis: from epidemiology and immunobiology to a rational diagnostic and therapeutic approach. 
  Chapter: Conventional medical management of ulcerative colitis: azathioprine. 
  Page 473 - 480Levesque BG, Loftus EVEditors: Baumgart DC.Springer, New York, NY2012
• Advanced Therapy in Inflammatory Bowel Disease. 
  Chapter: Metabolic bone disease in IBD patients: prevention and treatment. 
  Page 549 - 553Bayless TM, Hanauer SBPeople's Medical Publishing House, SheltonEdition 3rd,2011
• Ulcerative colitis: the complete guide to medical management. 
  Chapter: Management of refractory ulcerative colitis. 
  Page 319 - 330:Lichtenstein GR, Scherl EJSLACK, Thorofare, NJ2011
• Advanced Therapy in Inflammatory Bowel Disease. 
  Chapter: CT enterography and other small bowel imaging. 
  Page 185 - 188Bayless TM, Hanauer SBPeople's Medical Publishing House, SheltonEdition 3rd,2011
• Pocket Guide to IBD 2. 
  Chapter: Osteoporosis. 
  Page 157 - 163Dubinsky M, Friedman SSLACK, Thorofare, NJEdition 2nd,2011
• Inflammatory bowel disease. Translating basic science into clinical practice. 
  Chapter: Imaging in inflammatory bowel disease: computed tomography and magnetic resonance enterography, ultrasound and enteroscopy. 
  Page 266 - 278Targan SR, Shanahan F, Karp LCWiley-Blackwell, West Sussex, UK2010
• Chronic inflammation of liver and gut: Falk Symposium 163. 
  Chapter: Can we predict the natural history of ulcerative colitis? 
  Page 38 - 45Adler G, Jia JD, Fau DM, LaRusso N, Owyang CEditors: Adler G, Jia JD, Fau DM, LaRusso N, Owyang C.Springer, Dordrecht, Netherlands2009
• Curbside consultation in IBD: 49 clinical questions. 
  Chapter: What is the role of computed tomographic enterography in the diagnosis and management of inflammatory bowel disease? Has it replaced barium radiography? 
  Page 93 - 95Rubin DT, Friedman S, Farraye FASLACK, Thorofare, NJ2009
• Shackelford's surgery of the alimentary tract. 
  Chapter: Inflammatory bowel disease. 
  Page 2080 - 2100Yeo CJSaunders, Philadelphia, PAEdition 6th,2007
• GI epidemiology. 
  Chapter: Inflammatory bowel disease. 
  Page 198 - 206Loftus EV JrEditors: Talley NJ, Locke GR III, Saito YA.Blackwell, Malden, MA2006
• Mayo Clinic medical manual. 
  Chapter: Inflammatory bowel disease. 
  Page 641 - 652Loftus CG, Loftus EV JrEditors: Oliveira GHM, Nesbitt GC, Murphy JG.Mayo Clinic Scientific Press, Taylor & Francis Group, Boca Raton, FL2006
• Colitis: diagnosis and therapeutic strategies: Falk Symposium 147. 
  Chapter: Azathioprine: long-term side effects. 
  Page 142 - 151Loftus EVEditors: Jewell DP, Colombel JF, Pena AS, Tromm A, Warren BF.Springer, Dordrecht, Netherlands2006
• Pocket guide to inflammatory bowel disease. 
  Chapter: Osteoporosis. 
  Page 116 - 123Loftus EVEditors: Kane SV, Dubinsky MC.Cambridge University Press2005
• Kirsner's inflammatory bowel disease. 
  Chapter: Epidemiology of inflammatory bowel diseases. 
  Page 245 - 262Sandler RS, Loftus EV JrEditors: Sartor RB, Sandborn WJ.Saunders, Edinburgh, ScotlandEdition 6th,2004
• Mayo Clinic gastroenterology and hepatology board review. 
  Chapter: Inflammatory bowel disease: extraintestinal manifestations and cancer. 
  Page 195 - 2000Loftus EV JrEditors: Hauser SC.Mayo Clinic Scientific Press, Rochester, MN2004
• Self-assessment color review of gastroentology. 
  Chapter: Contributor of test questions and endoscopic photographs. 
  Loftus EVEditors: Gilinsky NH, Forbes A.Lippincott Williams and Wilkins, Philadelphia, PA1999
• Internal medicine. 
  Chapter: Diseases of small bowel absorption. 
  Page 2056 - 2068Charlton MR, Loftus EVJrEditors: Stein JH.Mosby, St. Louis, MO1998
• Advances in pancreatic disease: molecular biology, diagnosis and treatment. 
  Chapter: The spectrum of cystic neoplasms of the pancreas including mucinous ductal ectasia. 
  Page 352 - 370Sarr MG, Prabhakar LP, Loftus EVEditors: Dervenis CG.Georg Thieme Verlag, Stuttgart, Germany1996
• Join now to see all

Abstracts/Posters

• Biomarkers of neoplasm in ulcerative colitis.
  Garrity-Park M, Loftus E, Smyrk T, Inflamm Bowel Dis, 12/1/2013
• Osteonecrosis in inflammatory bowel disease: clinical features and outcomes.
  Yadav S, Loftus E, Tremaine W, Edakkanambeth Varayil J, Karls K, Inflamm Bowel Dis, 12/1/2013
• Histologic features of small bowel adenocarcinomas in Crohn's disease.
  Weber N, Smyrk T, Bruining D, Fletcher J, Fidler J, Pardi D, Loftus E, Inflamm Bowel Dis, 12/1/2013
• PYRAMID registry: an observational study of adalimumab in Crohn's disease: results at year 5.
  D'Haens G, Reinisch W, Satsangi J, Loftus E, Panaccione R, Castillo M, Kan-Dobrosky N, Eichner S, Thakkar R, Inflamm Bowel Dis, 12/1/2013
• Objectifying the Crohn's disease activity index (cdai): can we teach an old score new tricks?
  Morris M, Stewart S, Sandborn W, Loftus E, Fowler S, Jones J, Am J Gastroenterol, 10/1/2013
• Cumulative incidence of cancer in a population-based cohort of inflammatory bowel disease.
  Yadav S, Singh S, Edakkanambeth Varayil J, Tremaine W, Loftus E, Am J Gastroenterol, 10/1/2013
• Prevalence and outcomes of colonic serrated epithelial changes in patients with ulcerative colitis and Crohn's colitis.
  Johnson D, Khanna S, Smyrk O, Loftus E, Anderson K, Mahoney D, Ahlquist D, Kisiel J, Am J Gastroenterol, 10/1/2013
• Long-term effectiveness of adalimumab in Crohn's disease: observational data from the pyramid registry.
  Loftus E, D'Haen G, Reinisch W, Satsangi J, Panaccione R, Thakkar R, Eichner S, Castillo M, Kan-Dobrosky N, Skup M, Chao JD, Mulani P, Am J Gastroenterol, 10/1/2013
• A meta-analysis of risk of lymphoma in ibd patients: a comparison between patients actively using thiopurines and those with past use.
  Kotlyar D, Lewis J, Tierney A, Brensinger C, Beaugerie L, Loftus E, Blonski W, Van Domselaar M, Chaparro M, Sandilya S, Lichtenstein G, Am J Gastroenterol, 10/1/2013
• Clinical features and outcomes in patients with inflammatory bowel disease and concomitant sarcoidosis.
  Shahi V, Khanna S, Loftus E, Am J Gastroenterol, 10/1/2013
• Rising incidence of ischemic colitis in Olmsted County, Minnesota, 1976-2006: a population-based epidemiological study.
  Dave M, Siddhant Y, Harmsen WS, Tremaine WJ, Zinsmeister AR, Sweetser SR, Locke GR, Loftus EV, Gastroenterology, 5/1/2013
• Risk of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis.
  Singh S, Edakkanambeth Varayil J, Loftus E, Talwalkar J, Am J Gastroenterol, 1/1/2013
• Risk factors and outcomes of ischemic colitis in a population-based cohort.
  Yadav S, Dave M, Edakkanambeth Varayil J, Harmsen W, Tremaine W, Zinsmeister A, Sweetser S, Locke G, Sandborn W, Loftus E, Am J Gastroenterol, 1/1/2013
• Rate and predictors of possible missed esophageal and gastric cancers after esophagogastroduodenoscopy in the United States.
  Wang Y, Loftus E, Judge T, Peikin S, Am J Gastroenterol, 1/1/2013
• PYRAMID Registry: an observational study of adalimumab in Crohn's disease: results at year five.
  D'Haens G, Reinisch W, Satsangi J, Loftus E, Panaccione R, Castillo M, Kan-Dobrosky N, Eischner S, Thakkar R, Am J Gastroenterol, 1/1/2013
• Outcomes from fecal microbiota transplantation in adults with C.
  Khanna S, Kashyap P, Rainey J, Kammer P, Loftus E, Pardi D, Am J Gastroenterol, 1/1/2013
• Objectifying the Crohn's disease Crohn's Disease Activity Index (CDAI): can we teach an old score new tricks?
  Morris M, Stewart S, Sandborn W, Loftus E, Fowler S, Jones J, Am J Gastroenterol, 1/1/2013
• Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systemic review and meta-analysis.
  Singh S, Singh H, Loftus E, Pardi D, Am J Gastroenterol, 1/1/2013
• Intestinal wall remodeling on CT enterography may not predict improved bone health.
  Weber N, Fidler J, Clarke B, Khosla S, Fletcher J, Keaveny T, Lee D, Pardi D, Loftus E, Kane S, Barlow J, Bruining D, Am J Gastroenterol, 1/1/2013
• Inflammatory bowel disease does not impact mortality but increases length of hospitalization in patients with acute myocardial infarction.
  Dave M, Mehta K, Badheka D, Loftus E, Am J Gastroenterol, 1/1/2013
• Frequency of vitamin D testing and deficiency in Crohn's disease: a population-based study.
  Shivashankar R, Tremaine W, Harmsen W, Zinsmeister A, Loftus E, Am J Gastroenterol, 1/1/2013
• High levels of non-clonal serum immunoglobulin free light chains as biomarker of chronic inflammatory gastrointestinal disorders.
  Allen A, Thorneau T, Kim WR, Dispenzieri A, Kyle R, Loftus E, Roberts L, Rajkumar V, Am J Gastroenterol, 1/1/2013
• A predictive model incorporating clinical and endoscopic features for diagnosing Cytomegalovirus colitis in patients with inflammatory bowel disease.
  McCurdy J, Jones A, Loftus E, Bruining D, Enders F, Killian J, Smyrk T, Am J Gastroenterol, 1/1/2013
• Patients with inflammatory bowel disease co-infected with Clostridium difficile and Cytomegalovirus: rates of hospitalization and colectomy.
  McCurdy J, Jones A, Khanna S, Enders F, Killian J, Thapa P, Smyrk T, Bruining D, Loftus E, Am J Gastroenterol, 1/1/2013
• De novo Non-Skin Malignancy Risk After Liver Transplantation for Primary Sclerosing Cholangitis.
  Singh S, Talwalkar J, Watt KD, Loftus EV, Hay JE, Poterucha JJ, Charlton MR, Rosen CB, Heimbach JK, Wiesner R, Gastroenterology, 1/1/2013
• Join now to see all

Lectures

• What Causes IBD? 
  Lincolnshire, IL - 5/1/2014
• New Therapies for Inflammatory Bowel Disease. 
  Denver, CO - 4/1/2014
• The Newest Research Findings: New Medications for Crohn's and Colitis. 
  Atlanta, GA - 3/1/2014
• Optimizing Biologic Therapy: Maximizing Benefit and Minimizing Risk. 
  Atlanta, GA - 3/1/2014
• Malignancy in IBD: When to Suspect? 
  Kochi, India - 2/1/2014
• Environmental Factors-Research in IBD. 
  Kochi, India - 2/1/2014
• Isolated Periappendiceal Inflammation in UC. 
  Kochi, India - 2/1/2014
• Biologicals in Crohn's disease: Is that the final answer now. 
  Kochi, India - 2/1/2014
• Other Major Side Effects Due to Immunomodulators and/or Biologics in Our IBD Patients. 
  Hollywood, FL - 12/1/2013
• Pro: Immunomodulators Must Be Stopped When a Viral, Bacterial, or Fungal Infection Occurs. 
  Hollywood, FL - 12/1/2013
• Current and Evolving Treatment Paradigms in IBD. 
  Bismarck, ND - 11/1/2013
• Inflammatory Bowel Disease and Intestinal Disorders. 
  Berlin, Germany - 10/1/2013
• IBD Epidemiology State of the Art. 
  Berlin, Germany - 10/1/2013
• Optimal Use of Immunomodulators and Biologics. 
  San Diego, CA - 10/1/2013
• Practical Applications of Effective Disease Monitoring: The Concept of "Tight Control". 
  San Diego, CA - 10/1/2013
• Epidemiology of IBD: What's New. 
  Boston, MA - 9/1/2013
• Current and Future Treatment Paradigms of Inflammatory Bowel Disease. 
  Chicago, IL - 5/1/2013
• Continued Surveillance Should be Recommended for Low-Grade Dysplasia. 
  Philadelphia, PA - 3/1/2013
• Imaging in IBD: Alternatives to Routine CT Scans (MRI, Capsule, Deep Enteroscopy, Low-dose CT). 
  Philadelphia, PA - 3/1/2013
• New Therapies Update. 
  Bloomington, MN - 3/1/2013
• Challenges in Studying the Natural History of IBD. 
  Seattle, WA - 3/1/2013
• Descriptive Epidemiology of a Regional Longitudinal Cohort: the Olmsted County Experience. 
  2/1/2013
• Epidemiologic Research in IBD: Designing a Surveillance Program for IBD in the United States. 
  Philadelphia, PA - 2/1/2013
• The Role of Biologics in Crohn's Disease. 
  Scottsdale, Arizona - 2/1/2013
• Perianal Crohn's Disease. 
  Scottsdale, Arizona - 2/1/2013
• Join now to see all

Other

• Safety of TNF antagonists in Crohn's disease. 
  Loftus EV
  http://www.medscape.com/viewarticle/552616
  1/1/2007